Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Fust Matthew K
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   351,844    

Indirect Shares

  0      
Direct Value   $8,008,230    

Indirect Value

  $0      
Total Shares   351,844      
Total Value   $8,008,230      


Jazz Pharmaceuticals Inc
 $6,441,248 Ultragenyx Pharmaceutical Inc
 $596,480 Macrogenics Inc
 $2,045 Atara Biotherapeutics, Inc.
 $145,273 Crinetics Pharmaceuticals, Inc.
 $823,184 Jazz Pharmaceuticals Inc
 $6,441,248 Ultragenyx Pharmaceutical Inc
 $596,480 Macrogenics Inc
 $2,045 Atara Biotherapeutics, Inc.
 $145,273 Crinetics Pharmaceuticals, Inc.
 $823,184
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -24.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Jazz Pharmaceuticals Inc JAZZ EVP, Chief Financial O... 2008-11-28 58,948 0    Premium*  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Financial ... 2013-10-01 0 2009-01-05 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE 2024-03-07 14,860 2014-01-30 0    Premium*  
            Macrogenics Inc MGNX Director 2019-02-06 500 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA 2024-03-31 259,000 2015-05-15 0    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX Director 2024-03-20 18,536 2019-12-16 0    Premium*  
* Premium Members only  

Records found :    96         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2010-03-31 4 A $0.00 $0 D/D 6,500 18,081 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2011-01-06 4 AS $37.28 $67,551 D/D (1,812) 18,101 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2011-03-31 4 A $0.00 $0 D/D 28,500 46,601 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2011-04-01 4 AS $35.02 $28,016 D/D (800) 45,801 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2011-11-18 4 AS $38.05 $32,989 D/D (867) 45,310 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2012-01-06 4 AS $43.46 $77,750 D/D (1,789) 43,829 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2012-02-14 4 OE $34.48 $172,400 D/D 5,000 48,829 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2012-03-02 4 AS $37.52 $22,212 D/D (592) 48,237 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2012-07-25 4 AS $73.97 $385,171 D/D (5,207) 67,924 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2012-08-06 4 S $71.63 $1,578,267 D/D (22,009) 63,407 0 -
ONXX Onyx Pharmaceuticals Inc Chief Financial Officer   •       –      –    2012-08-06 4 OE $34.48 $603,124 D/D 17,492 85,416 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2012-11-28 4 OE $34.48 $33,308 D/D 966 53,123 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-01-10 4 AS $84.41 $865,582 D/D (10,199) 50,201 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-01-10 4 OE $34.48 $245,222 D/D 7,112 60,400 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-02-28 4 AS $77.12 $1,156,800 D/D (15,000) 45,201 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-02-28 4 OE $34.48 $344,800 D/D 10,000 60,201 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-03-05 4 OE $34.48 $76,235 D/D 2,211 47,412 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-03-28 4 A $0.00 $0 D/D 8,000 55,412 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-04-01 4 AS $86.13 $332,575 D/D (3,861) 51,551 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-04-15 4 AS $95.15 $128,167 D/D (1,347) 50,204 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-05-13 4 AS $97.54 $1,008,598 D/D (10,269) 50,204 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-05-13 4 OE $34.48 $354,075 D/D 10,269 60,473 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-07-02 4 AS $132.80 $205,973 D/D (1,551) 48,838 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-07-26 4 AS $130.50 $788,612 D/D (6,043) 42,795 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Financial Officer   •       –      –    2013-08-08 4 AS $128.21 $319,499 D/D (2,492) 40,303 0 -

  96  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed